Trimi vs BreezeMeds: pricing, shipping, compounded meds compared
Quick verdict: Trimi emphasizes compounded semaglutide from $99/mo with flat pricing and free overnight, temperature-controlled shipping, while BreezeMeds lists semaglutide injection starting at $199/mo and offers injectable and oral GLP-1 options; choose based on whether you prioritize lower flat compounded pricing and a stated refund policy (Trimi) or multiple product formats and published starting prices for both injectable and oral options (BreezeMeds).
View Trimi compounded pricing and plans
How Trimi vs BreezeMeds compare at a glance
This comparison uses only the supplied facts and preserves qualifiers. Below are the most distinctive differences: starting price and pricing model, medication formats and product types, shipping and delivery promises, and regulatory/compounding notes and refund terms. The primary keyword appears throughout for relevance: Trimi vs BreezeMeds.
| Criteria | Trimi | BreezeMeds |
|---|---|---|
| Starting price | Semaglutide from $99/mo on the annual plan; tirzepatide $125/mo | Semaglutide injection from $199/mo; tirzepatide injection from $299; oral options from $399 |
| Pricing model | Flat pricing every dose – same price at every dose; one flat membership covers medication and clinician visits | Starting-at pricing displayed for multiple formats; a $169 figure appears without clear product association |
| Medication formats | Compounded semaglutide and tirzepatide prescribed and shipped | Injectable and oral semaglutide and tirzepatide options displayed |
| Shipping & delivery | Free overnight, temperature-controlled shipping | Discreet home delivery; shipping described as discreet |
| Refunds and commitments | Not approved by medical team? 100% automatic refund; 6-month money-back promise, terms apply | Fees and billing commitments were not fully visible; no refund policy captured in source |
Pricing and membership differences
Trimi vs BreezeMeds shows a clear pricing distinction. Trimi advertises compounded semaglutide from $99/mo on the annual plan and tirzepatide at $125/mo, plus a flat pricing model where price does not rise with dose. BreezeMeds lists semaglutide injection starting at $199/mo, tirzepatide injection from $299, and oral options from $399, and a separate $169 figure appears without a clear product association. The source for Trimi specifically notes flat pricing every dose and an annual-plan starting price; BreezeMeds presents multiple starting-at prices and some pricing ambiguity.
See BreezeMeds starting prices and options
Medication formats and compounding
Both providers display GLP-1 treatments, but formats differ. Trimi emphasizes compounded semaglutide and compounded tirzepatide prescribed by US-licensed clinicians. The source repeatedly notes that compounded medications are prepared per individual prescription and are not themselves FDA-approved. BreezeMeds displays injectable and oral semaglutide and tirzepatide options; the source flags that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. If compounding status matters to you, the comparison is an important factor between Trimi and BreezeMeds.
Check Trimi compounded medication details
Shipping, clinician review, and refunds
Trimi states free overnight, temperature-controlled shipping and that prescriptions are reviewed by licensed US clinicians via Arora Health; Trimi also advertises a 6-month money-back promise and an automatic refund if not approved by their medical team, with terms applying. BreezeMeds emphasizes discreet home delivery and clinician-reviewed treatment; its source copy asks what states they service and what costs and insurance terms apply, and notes that fees and billing commitments were not fully visible. Both providers require a licensed clinician to determine medical appropriateness according to captured evidence.
Review BreezeMeds delivery and eligibility
Regulatory and safety notes
Preserve the source qualifiers: Trimi explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. The comparison does not include any clinical effectiveness claims beyond the source statements that cite peer-reviewed trials for active ingredients, which are not guarantees of individual results.
Final comparison and how to choose
Trimi vs BreezeMeds centers on whether you prioritize lower flat compounded pricing and an explicit refund promise or a provider that displays multiple injectable and oral product formats with higher listed starting prices. Trimi: compounded semaglutide from $99/mo on the annual plan, flat price at every dose, free overnight shipping, 6-month money-back promise, and clinician oversight via Arora Health. BreezeMeds: semaglutide injection starting at $199/mo, tirzepatide injection starting at $299, oral options starting at $399, discreet shipping, and clinician-reviewed treatment with some pricing items not fully clear in the source.
Choose Trimi if you want flat compounded pricing starting at $99/mo, free overnight shipping, and a stated 6-month refund option. Choose BreezeMeds if you prefer a provider that lists injectable and oral GLP-1 formats with starting prices visible for each format, and discreet home delivery. This guidance is based only on the supplied source facts and qualifiers for Trimi vs BreezeMeds.